| 余波 | 复旦大学附属肿瘤医院 | 新型肿瘤药物管理与临床药学学术发展 |
| Ming POI | Ohio State University, The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, | 靶向抗肿瘤药物PK/PD对预后的影响 |
| 翟青 | 复旦大学附属肿瘤医院 | 从我院临床实验研究课题谈肿瘤药物研发趋势 |
| Alax CHAN | Singapore National University, Singapore National Cancer Center | 肿瘤患者长期生存质量研究 |
| 李权 | Ohio State University, The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, | 抗肿瘤综合治疗病例讨论 |
| Harbans Dhillon | Malaya University Medical Center, Malaysia | 肿瘤药学服务指南 |
| Judith SMITH | The University of Texas Health Science Center at Houston | 靶向抗肿瘤药物耐药机制及研究热点 |
| Theresa A MAYS | South Texas Accelerated Research Therapeutics, US | 肿瘤药物服务实践 |
| 胡夕春 | 复旦大学附属肿瘤医院 | 肿瘤分子靶向治疗进展 |